eClinicalOS(TM) Mobile App Breaks New Ground for Clinical

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
eClinicalOS(TM) Mobile App Breaks New Ground for Clinical Researchers

MORRISVILLE, N.C., June 3, 2015 (GLOBE NEWSWIRE) -- Study Connect™, a new mobile app from Merge eClinical , allows eClinicalOS (eCOS) users to perform a wide array of clinical trial management functions from their iOS-based mobile devices.

Seamlessly integrated with eCOS, Study Connect™ enables researchers to:

  • Manage randomization of subjects
  • Coordinate dispensing and inventory management
  • Unblind individual subjects, as circumstances warrant
  • Stay connected with real-time customized notifications
  • Monitor enrollment and establish milestone alerts
  • Share top-level statistics for each study with key stakeholders using the study dashboard
  • Expedite approval response times for critical study decisions such as patient study eligibility
  • Maintain security with the ability to set customized role-based permissions for individual studies.

"We're pushing the boundaries of what's possible in a mobile environment for clinical researchers," said Zaher El-Assi, president of Merge eClinical. "More and more, researchers need to be able to perform virtually any study task from their tablets and smartphones. Managing study decisions and being notified of adverse events alone would make for a useful mobile EDC, but Study Connect gives eCOS users so much more. It really serves as a natural extension of their desktops and laptops."

According to Mr. El-Assi, while there are a handful of mobile clinical research apps on the market, nearly all are limited solely to patient-reporting functions.

"With more studies being conducted at multiple sites across multiple time zones around the world, it's critical that researchers not just be able to monitor crucial study variables, but also to respond to them in real time," he said. "There are few, if any, other industries where the consequences of the old 'time-is-money' adage are felt more acutely than in drug development. By giving eCOS users more power to do more tasks while on the go, we're helping them make the most of every minute."

Mr. El-Assi noted that in many less-developed countries cellular networks are often more reliable than electricity, meaning that vital study functions need not cease when power grids fail.

Study Connect is available in the App Store and can be reached through this link. Designed to work on both the iPad™ and iPhone™, Study Connect can be integrated into existing trials through the Clinical Configurator, the company's exclusive online tool for the planning and budgeting of studies on the eCOS platform.

"While Merge eClinical is exceptionally proud to be among the first EDC providers to offer true mobile study management capabilities, we've only scratched the surface of what's possible," said Mr. El-Assi. "Our R&D team is already working on the next update to Study Connect, and we're excited to see what ideas eCOS users send to us on how they think we can make it an even more useful app for them."

About Merge eClinical

Merge eClinical is a division of Merge Healthcare, Inc. (Nasdaq: MRGE ), a leading provider of clinical systems and innovations that seek to transform healthcare. eClinicalOS (eCOS) the company's flagship product, is a single, scalable, cloud-based platform researchers can configure to suit a study's precise needs. From monitoring inventory and managing randomization to endpoint adjudication and archiving results, users pay only for the options they use. Studies built within eCOS can launch in as few as 10 days, and the average deployment time from project start is 40 days. Through active sites in 80-plus countries, more than 50,000 clinical research professionals in small and large organizations have entrusted their study management needs to eCOS. More information is available at www.eclinicalos.com , and you can follow us at @goecos .

About Merge

Merge is a leading provider of innovative enterprise imaging, interoperability and clinical systems that seek to advance healthcare. Merge's enterprise and cloud-based technologies for image intensive specialties provide access to any image, anywhere, any time. Merge also provides clinical trials software with end-to-end study support in a single platform and other intelligent health data and analytics solutions. With solutions that have been used by providers for more than 25 years, Merge is helping to reduce costs, improve efficiencies and enhance the quality of healthcare worldwide. For more information, visit merge.com and follow us @MergeHealthcare .

Media Contact: Aaron Mazze Merge eClinical (919) 653-3467

Scroll down for more posts ▼

Top 10 Most Recent News Articles

3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 229

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 193

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 411

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 211

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 211

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 221

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 182

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 187

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 304

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 286

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading

Top 5 Most Recently Viewed Articles

Zixi Unveils Advanced Video Solutions for Live Sports in 2025

Updated Category News Views 319

Zixi's Innovative Showcase at IBC 2025 IBC stand 5.A85 Zixi, the Emmy Award-winning leader in broadcast-quality live video over IP, is set to exhibit at IBC 2025 held in Amsterdam. At Stand 5.A85, the company will reveal groundbreaking innovations aimed at enhancing the live video experience for broadcasters, sports leagues, service providers, and OTT platforms. With a...

Continue Reading
Discover the Incredible Growth of Agnico Eagle Mines Over 20 Years

Updated Category News Views 165

Discovering the Long-Term Success of Agnico Eagle Mines Agnico Eagle Mines (NYSE: AEM) has demonstrated impressive performance in the stock market over the last 20 years. With a remarkable average annual return of 9.52%, the company has outperformed the market by 1.17% each year. Currently, Agnico Eagle holds a market valuation of $41.72 billion, showcasing its strong...

Continue Reading
Join the Race for Excellence in Bartending Skills Today

Updated Category News Views 276

USBG Presents World Class Sponsored By DIAGEO Launches Bartender Competition The esteemed bartending competition is now open for applications, inviting skilled mixologists to step into the limelight for a chance to become the 2025 U.S. Bartender of the Year. With application deadlines coming up quickly, anyone with the passion, creativity, and skill should take advantage...

Continue Reading
Sunflower Therapeutics Secures $3 Million SAFE for Future Growth

Updated Category News Views 370

Sunflower Therapeutics Secures Oversubscription of $3 Million SAFE Sunflower Therapeutics, a public benefit corporation dedicated to improving global protein manufacturing, recently announced the successful oversubscription of a $3 million Simple Agreement for Future Equity (SAFE). This achievement illustrates strong investor confidence in the company's mission to enhance...

Continue Reading
Future Growth of Video Surveillance Market Projected to Soar

Updated Category News Views 42

Forecast for Video Surveillance Market Growth The video surveillance market is witnessing remarkable expansion, with a projected value of USD 54.42 billion by the year 2024 and an impressive rise to USD 88.71 billion anticipated by 2030. This growth represents a compounded annual growth rate (CAGR) of 8.5% during the upcoming forecast period. Various factors contribute to...

Continue Reading